Author: Expert Panel on Radiation Oncology–Head & Neck Cancer, Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Harry Quon, Ridge JA, Saba NF, Worden F, Yao M, Salama JK
Year: 2016
AGREE II score: Available
Developer organization: American College of Radiology
Type of cancer: Head and neck and oropharyngeal
Patient population: Adult
Location: International
This guideline reviews clinical presentation and patient evaluation, prognostic factors, principles of management, and treatment outcomes for patients with nasal cavity and paranasal sinus cancers. Surgery, radiotherapy, and chemotherapy are discussed as treatment options. Special topics of interest include the management of cervical lymph nodes and the management of unusual pathologies of nasal cavity cancers, namely esthesioneuroblastoma and sinonasal undifferentiated carcinoma.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 38.9%
Applicability: 8.3%
Stakeholder involvement: 25%
Editorial independence: 29.2%
Rigour: 79.2%
Clarity presentation: 69.4%
